亚宝药业: 亚宝药业集团股份有限公司关于取得金融机构股票回购贷款承诺函的公告

Group 1 - The company has approved a share repurchase plan with a total funding amount between RMB 50 million and RMB 100 million, with a maximum repurchase price of RMB 6.95 per share [1][2] - The repurchase will be conducted through centralized bidding and aims to cancel the repurchased shares, thereby reducing the registered capital of the company [1] - The repurchase period is set for a maximum of 6 months from the date of the shareholders' meeting approval [1] Group 2 - The company has obtained a loan commitment letter from the Bank of China, with a maximum loan amount of RMB 90 million and a loan term not exceeding 3 years [2] - The loan is intended to support the company's share repurchase activities [2] - The actual repurchase amount will be determined based on the market conditions and the availability of funds at the end of the repurchase period [2]